Atlas Trials

Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

RecordFirmDate
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)National Cancer Institute (NCI)2021-08-09
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (NCT03914612)National Cancer Institute (NCI)2019-08-22
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone (NCT03660826)National Cancer Institute (NCI)2018-09-27
Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer (NCT03367741)National Cancer Institute (NCI)2018-04-16

Track Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.